ALBRIGHT HEREDITARY OSTEODYSTROPHY
Clinical trials for ALBRIGHT HEREDITARY OSTEODYSTROPHY explained in plain language.
Never miss a new study
Get alerted when new ALBRIGHT HEREDITARY OSTEODYSTROPHY trials appear
Sign up with your email to follow new studies for ALBRIGHT HEREDITARY OSTEODYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Old asthma drug may help kids with rare genetic condition
Disease control OngoingThis study is testing whether theophylline, a medication historically used for asthma, can help children and young adults with pseudohypoparathyroidism. This rare genetic disorder causes early obesity, short stature, and increased diabetes risk. Researchers will give participants…
Matched conditions: ALBRIGHT HEREDITARY OSTEODYSTROPHY
Phase: PHASE2 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Apr 04, 2026 06:21 UTC
-
Old asthma drug may help kids with rare genetic disorder
Disease control OngoingThis study is testing whether theophylline, a medication long used for asthma, can help children with a rare genetic disorder called pseudohypoparathyroidism. Researchers want to see if the drug helps with weight loss, slows bone maturation to allow for more growth, and reduces t…
Matched conditions: ALBRIGHT HEREDITARY OSTEODYSTROPHY
Phase: PHASE2 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
Hope for rare disorder: Two-Year drug trial tests weight and hormone benefits
Disease control ENROLLING_BY_INVITATIONThis study is testing the long-term safety and effects of a drug called theophylline in people with a rare genetic disorder called pseudohypoparathyroidism. It involves about 34 children and young adults who have already completed a previous related trial. The main goals are to s…
Matched conditions: ALBRIGHT HEREDITARY OSTEODYSTROPHY
Phase: PHASE2 • Sponsor: Ashley Shoemaker • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC